Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03166579
Other study ID # NOSP
Secondary ID
Status Completed
Phase N/A
First received May 22, 2017
Last updated May 23, 2017
Start date July 2010
Est. completion date August 2016

Study information

Verified date May 2017
Source Health Service Executive, Ireland
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the effectiveness of Dialectical Behaviour Therapy for adults with Borderline Personality Disorder attending Community Mental Health Services in Cork, Ireland.

The main objective of the current study is to determine if completion of a 12 month DBT programme is associated with improved outcomes in terms of borderline symptoms, anxiety, hopelessness, suicidal behaviour, depression and quality of life.

A secondary objective includes assessing client progress across multiple time-points throughout the treatment.


Description:

Dialectical Behaviour Therapy (DBT) is noted to be an intervention with a growing evidence base which demonstrates its effectiveness in treating individuals with Borderline Personality Disorder (BPD). Nine randomised controlled trials have been completed at six independent sites. These trials have found a reduction in suicidal behaviours, intentional self-injury, depression, hopelessness and other difficulties associated with this mental health diagnosis.

While the efficacy of DBT has been demonstrated through multiple RCTs, few studies have examined the effectiveness of DBT in community mental health settings. In particular, no study to our knowledge has evaluated the standard 12-month DBT programme for adults with BPD in an Irish community setting. "Standard" DBT is delivered by a team of multidisciplinary mental health professionals, and comprises of individual therapy sessions for each patient, group skills training sessions, phone coaching and consultation meetings for the clinicians on the DBT team.

The current study thus aims to evaluate the effectiveness of the standard 12-month DBT programme (The Endeavour Programme) in an Irish community setting.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Meet criteria for diagnosis of either Borderline Personality Disorder (DSM IV/V) or Emotionally Unstable Personality Disorder (ICD-10)

- Current emotion and behavioural dysregulation

- A history of self-harm behaviour

- The client will have discussed the diagnosis with a member of the DBT team and will have expressed an interest in, and commitment to the 12 month programme.

Exclusion Criteria:

- An active psychosis

- If the client has severe developmental delays, cognitive impairment or learning disabilities (exceeding mild range)

- If a clients' substance/drug dependence, eating disorder or any other mental health issue/behaviour is at such a level that it would impede their engaging with any of the modalities of DBT

Study Design


Intervention

Behavioral:
Dialectical Behaviour Therapy
Dialectical Behaviour Therapy (DBT) is a psychological intervention which was originally developed for women with Borderline Personality Disorder. DBT is delivered by a team of multidisciplinary mental health professionals, and comprises of individual therapy sessions for each patient, group skills training sessions, phone coaching and consultation meetings for the clinicians on the DBT team. Group skills are delivered in blocks of three modules which teach mindfulness, distress tolerance, emotion regulation and interpersonal effectiveness. The three modules are delivered over a 24-week period and are then repeated.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Health Service Executive, Ireland

Outcome

Type Measure Description Time frame Safety issue
Primary Borderline Symptoms Borderline Symptom List (BSL-23). The BSL-23 is a self-report questionnaire which comprises 23 items measuring borderline-typical symptomatology. 12 months from pre-intervention to post-intervention
Primary Suicidal ideation Beck Scale for Suicide Ideation (BSS). The BSS is a 21-item self-report assessment developed to identify individuals at risk of suicide. 12 months from pre-intervention to post-intervention
Primary Hopelessness Beck Hopelessness Scale (BHS). The BHS is a 20 item self-report measure which assesses key aspects of hopelessness. 12 months from pre-intervention to post-intervention
Primary Depression Beck Depression Inventory - Second Edition (BDI-II). The BDI-II is a 21 item self-report measure of symptoms and attitudes related to depression. 12 months from pre-intervention to post-intervention
Primary Anxiety Beck Anxiety Inventory (BAI). The BAI is a 21 is self-report multiple choice survey which evaluates both physiological and cognitive symptoms of anxiety 12 months from pre-intervention to post-intervention
Primary Quality of Life World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF). The WHOQOL-BREF was developed collaboratively in a number of centres to act as an international cross-culturally comparable quality of life assessment. It comprises 26 items across four domains: physical health (domain 1), psychological health (domain 2), social relationships (domain 3), and environment (domain 4). 12 months from pre-intervention to post-intervention
See also
  Status Clinical Trial Phase
Completed NCT03011190 - Effectiveness of the Iconic Therapy for Borderline Personality Disorder Symptoms N/A
Completed NCT00247234 - Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders N/A
Recruiting NCT05765864 - Self-harm Behaviour Among the Most At-risk Adolescents
Completed NCT04259554 - OFC rTMS in Emotionally Unstable and Depressed Patients N/A
Completed NCT03180541 - Evaluating the Coordinated National Implementation of DBT in Ireland N/A